Krka has maintained its strong performance in 2024 as seen in its latest nine-month results despite slightly missing net profit consensus forecasts amid ongoing questions surrounding the company’s business in Russia and risks linked to the country’s currency.
Overall, Krka reported revenue of €1.43bn ($1.51bn) in the past nine months, which marked a 7% year-on-year increase. Alongside this,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?